News Headlines Article

Lilly to sell cheaper version of top-selling insulin Humalog
Modern Healthcare

Eli Lilly is offering a half-price version of its top-selling insulin Humalog as drugmakers face growing pressure to control prices.

The company says it will introduce a version of the diabetes treatment called Insulin Lispro with a list price 50% lower than its current rate of about $275 per vial.

The discounted insulin will sell for $137.35 per vial or $265.20 for a five pack of Kwik Pens.